Shopping Cart 0
Cart Subtotal
USD 0

Global Blood Screening Market to reach USD 3.94 billion by 2026.

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4950

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6250

Details

Global Blood Screening Market is valued approximately at USD 2.02 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.70% over the forecast period 2019-2026. A Blood screening is a medical process in which blood is examined for a specific condition and it helps to monitor disease and a variety of other conditions such any sort of infection or disease. Blood Screening technology is widely used in various fields of diagnostics of diseases such as HIV, Cancer and infections. Additionally, Blood Screening to witness prominent growth owing to the incorporation of nucleic acid amplification test and advancements in blood screening tests. As a result, the demand & adoption for blood screening would increase thereby, making its way for the growth of the market. The growth of the market is primarily driven by the prevalence of infectious diseases and demand for safe blood units. For Instance: According to the LANCET Public Health in 2017, the incidence of HIV has increased from 0.23 per 100,000 in 2004 to approx. 4.2 per 100,000 individuals in 2017. Similarly, as per the SupChina Organization in China, the surge in the number of HIV-infected people increased from 759,000 in 2017 to approx. 1.2 million in 2018. Similarly, as per the National Center for Health Statistics in 2017, around 54,285 new cases of salmonella were reported across United States. As a result, the demand and need for blood screening tests would increase as these tests are widely utilized to observe, screen and assess to analyze human conditions. Furthermore, emergence of multiplexing and microbiology screening are also expected to set various opportunities for the growth of the market. However, high initial set up cost and complex regulations for blood bank and screening test is expected to impede the growth of the market over the forecast period.
 
The regional analysis of global Blood Screening market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is expected to hold a notable share in the world in terms of revenue owing to the growing prevalence of infectious diseases along with the increasing demand for donated blood. The dominance of the region is witnessed owing to the presence of the well-established infrastructure for hospitals and clinical laboratories and increasing prevalence of newer pathogens. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period. Factors such as rising public-private initiative aimed towards boosting advance research practices and increase investment to promote blood screening research is expected to create lucrative prospects for the growth pf the region during the forecast period of 2019-2026.
 
Major market player included in this report are:
Grifols S.A
F. Hoffmann-La Rochen AG
Abbott Laboratories
Biomerieux
Bio-Rad Laboratories Inc.
Becton, Dickson and Company
Danaher Corporation
Ortho Clinical Diagnostics
Siemens Healthineers AG
Thermo Fisher Scientific
 
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Reagents & Kits
Instruments
Software & Services
By Technology:
Nucleic Acid Testing
ELISA
Rapid Tests
Western Blot Assays
Next Generation Sequencing (NGS)
By End-User:
Blood Banks
Hospitals
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year-2016, 2017
Base year-2018
Forecast period-2019 to 2026
Target Audience of the Global Blood Screening Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
READ MORE

Table Of Content

Scope

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)

1.2.1. Blood Screening Market, by Region, 2017-2026 (USD Million)

1.2.2. Blood Screening Market, by Technology, 2017-2026 (USD Million)

1.2.3. Blood Screening Market, by Product , 2017-2026 (USD Million)

1.2.4. Blood Screening Market, by End-User, 2017-2026 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Blood Screening Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Blood Screening Market Dynamics

3.1. Blood Screening Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Blood Screening Market: Industry Analysis

4.1. Porter's 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Blood Screening Market, by Technology

5.1. Market Snapshot

5.2. Global Blood Screening Market by Technology, Performance-Potential Analysis

5.3. Global Blood Screening Market Estimates & Forecasts by Technology , 2016-2026 (USD Million)

5.4. Blood Screening Market, Sub Segment Analysis

5.4.1. Nucleic Acid Testing

5.4.2. ELISA

5.4.3. Rapid Tests

5.4.4. Western Blot Assays

5.4.5. Next Generation Sequencing (NGS)

Chapter 6. Global Blood Screening Market, by Product

6.1. Market Snapshot

6.2. Global Blood Screening Market by Product , Performance-Potential Analysis

6.3. Global Blood Screening Market Estimates & Forecasts by Product 2016-2026 (USD Million)

6.4. Blood Screening Market, Sub Segment Analysis

6.4.1. Reagents & Kits

6.4.2. Instruments

6.4.3. Software & Services

Chapter 7. Global Blood Screening Market, by End-User

7.1. Market Snapshot

7.2. Global Blood Screening Market by End-User , Performance-Potential Analysis

7.3. Global Blood Screening Market Estimates & Forecasts by End-User 2016-2026 (USD Million)

7.4. Blood Screening Market, Sub Segment Analysis

7.4.1. Blood Banks

7.4.2. Hospitals

Chapter 8. Global Blood Screening Market, Regional Analysis

8.1. Blood Screening Market, Regional Market Snapshot

8.2. North America Blood Screening Market

8.2.1. U.S. Blood Screening Market

8.2.1.1. Product breakdown estimates & forecasts, 2016-2026

8.2.1.2. Technology Industry breakdown estimates & forecasts, 2016-2026

8.2.1.3. End-user breakdown estimates & forecasts, 2016-2026

8.2.2. Canada Blood Screening Market

8.3. Europe Blood Screening Market Snapshot

8.3.1. U.K. Blood Screening Market

8.3.2. Germany Blood Screening Market

8.3.3. Rest of Europe Blood Screening Market

8.4. Asia-Pacific Blood Screening Market Snapshot

8.4.1. China Blood Screening Market

8.4.2. India Blood Screening Market

8.4.3. Japan Blood Screening Market

8.4.4. Rest of Asia Pacific Blood Screening Market

8.5. Latin America Blood Screening Market Snapshot

8.5.1. Brazil Blood Screening Market

8.5.2. Mexico Blood Screening Market

8.6. Rest of The World Blood Screening Market

 

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Grifols S.A

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. F. Hoffmann-La Roche AG

9.2.3. Abbott Laboratories

9.2.4. Biomerieux

9.2.5. Bio-Rad Laboratories Inc.

9.2.6. Becton, Dickson and Company

9.2.7. Danaher Corporation

9.2.8. Ortho Clinical Diagnostics

9.2.9. Siemens Healthineers AG

9.2.10. Thermo Fisher Scientific

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption


List Of Figure

FIG 1. GLOBAL BLOOD SCREENING MARKET, RESEARCH METHODOLOGY

FIG 2. GLOBAL BLOOD SCREENING MARKET, MARKET ESTIMATION TECHNIQUES

FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS

FIG 4. GLOBAL BLOOD SCREENING MARKET, KEY TRENDS 2018

FIG 5. GLOBAL BLOOD SCREENING MARKET, GROWTH PROSPECTS 2019-2026

FIG 6. GLOBAL BLOOD SCREENING MARKET, PORTERS 5 FORCE MODEL

FIG 7. GLOBAL BLOOD SCREENING MARKET, PEST ANALYSIS

FIG 8. GLOBAL BLOOD SCREENING MARKET, VALUE CHAIN ANALYSIS

FIG 9. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 10. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 11. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 12. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 13. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 14. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 15. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 16. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 17. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 18. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 19. GLOBAL BLOOD SCREENING MARKET, REGIONAL SNAPSHOT 2016 & 2026

FIG 20. NORTH AMERICA BLOOD SCREENING MARKET 2016 & 2026 (USD MILLION)

FIG 21. EUROPE BLOOD SCREENING MARKET 2016 & 2026 (USD MILLION)

FIG 22. ASIA PACIFIC BLOOD SCREENING MARKET 2016 & 2026 (USD MILLION)

FIG 23. LATIN AMERICA BLOOD SCREENING MARKET 2016 & 2026 (USD MILLION)

FIG 24. GLOBAL BLOOD SCREENING MARKET, COMPANY MARKET SHARE ANALYSIS (2018)


List Of Table

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BLOOD SCREENING MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BLOOD SCREENING MARKET

TABLE 3. GLOBAL BLOOD SCREENING MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)

TABLE 7. GLOBAL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD MILLION)

TABLE 8. GLOBAL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)

TABLE 9. GLOBAL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)

TABLE 10. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 11. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 12. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 13. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 14. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 15. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 16. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 17. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 18. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 19. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 20. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 21. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 22. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 23. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 24. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 25. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 26. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 27. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 28. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 29. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 30. U.S. BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 31. U.S. BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 32. U.S. BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 33. U.S. BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 34. CANADA BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 35. CANADA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 36. CANADA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 37. CANADA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 38. UK BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 39. UK BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 40. UK BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 41. UK BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 42. GERMANY BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 43. GERMANY BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 44. GERMANY BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 45. GERMANY BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 46. ROE BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 47. ROE BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 48. ROE BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 49. ROE BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 50. CHINA BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 51. CHINA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 52. CHINA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 53. CHINA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 54. INDIA BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 55. INDIA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 56. INDIA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 57. INDIA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 58. JAPAN BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 59. JAPAN BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 60. JAPAN BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 61. JAPAN BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 62. ROAPAC BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 63. ROAPAC BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 64. ROAPAC BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 65. ROAPAC BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 66. BRAZIL BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 67. BRAZIL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 68. BRAZIL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 69. BRAZIL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 70. MEXICO BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 71. MEXICO BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 72. MEXICO BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 73. MEXICO BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 74. ROLA BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 75. ROLA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 76. ROLA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 77. ROLA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 78. ROW BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 79. ROW BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 80. ROW BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 81. ROW BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Global Blood Screening Market


Companies

Grifols S.A

F. Hoffmann-La Rochen AG

Abbott Laboratories

Biomerieux

Bio-Rad Laboratories Inc.

Becton, Dickson and Company

Danaher Corporation

Ortho Clinical Diagnostics

Siemens Healthineers AG

Thermo Fisher Scientific

Company Profile

Company Profile Title

Global Blood Screening Market is valued approximately at USD 2.02 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.70% over the forecast period 2019-2026. A Blood screening is a medical process in which blood is examined for a specific condition and it helps to monitor disease and a variety of other conditions such any sort of infection or disease. Blood Screening technology is widely used in various fields of diagnostics of diseases such as HIV, Cancer and infections. Additionally, Blood Screening to witness prominent growth owing to the incorporation of nucleic acid amplification test and advancements in blood screening tests. As a result, the demand & adoption for blood screening would increase thereby, making its way for the growth of the market. The growth of the market is primarily driven by the prevalence of infectious diseases and demand for safe blood units. For Instance: According to the LANCET Public Health in 2017, the incidence of HIV has increased from 0.23 per 100,000 in 2004 to approx. 4.2 per 100,000 individuals in 2017. Similarly, as per the SupChina Organization in China, the surge in the number of HIV-infected people increased from 759,000 in 2017 to approx. 1.2 million in 2018. Similarly, as per the National Center for Health Statistics in 2017, around 54,285 new cases of salmonella were reported across United States. As a result, the demand and need for blood screening tests would increase as these tests are widely utilized to observe, screen and assess to analyze human conditions. Furthermore, emergence of multiplexing and microbiology screening are also expected to set various opportunities for the growth of the market. However, high initial set up cost and complex regulations for blood bank and screening test is expected to impede the growth of the market over the forecast period.
 
The regional analysis of global Blood Screening market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is expected to hold a notable share in the world in terms of revenue owing to the growing prevalence of infectious diseases along with the increasing demand for donated blood. The dominance of the region is witnessed owing to the presence of the well-established infrastructure for hospitals and clinical laboratories and increasing prevalence of newer pathogens. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period. Factors such as rising public-private initiative aimed towards boosting advance research practices and increase investment to promote blood screening research is expected to create lucrative prospects for the growth pf the region during the forecast period of 2019-2026.
 
Major market player included in this report are:
Grifols S.A
F. Hoffmann-La Rochen AG
Abbott Laboratories
Biomerieux
Bio-Rad Laboratories Inc.
Becton, Dickson and Company
Danaher Corporation
Ortho Clinical Diagnostics
Siemens Healthineers AG
Thermo Fisher Scientific
 
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Reagents & Kits
Instruments
Software & Services
By Technology:
Nucleic Acid Testing
ELISA
Rapid Tests
Western Blot Assays
Next Generation Sequencing (NGS)
By End-User:
Blood Banks
Hospitals
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year-2016, 2017
Base year-2018
Forecast period-2019 to 2026
Target Audience of the Global Blood Screening Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
READ MORE

Scope

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)

1.2.1. Blood Screening Market, by Region, 2017-2026 (USD Million)

1.2.2. Blood Screening Market, by Technology, 2017-2026 (USD Million)

1.2.3. Blood Screening Market, by Product , 2017-2026 (USD Million)

1.2.4. Blood Screening Market, by End-User, 2017-2026 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Blood Screening Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Blood Screening Market Dynamics

3.1. Blood Screening Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Blood Screening Market: Industry Analysis

4.1. Porter's 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Blood Screening Market, by Technology

5.1. Market Snapshot

5.2. Global Blood Screening Market by Technology, Performance-Potential Analysis

5.3. Global Blood Screening Market Estimates & Forecasts by Technology , 2016-2026 (USD Million)

5.4. Blood Screening Market, Sub Segment Analysis

5.4.1. Nucleic Acid Testing

5.4.2. ELISA

5.4.3. Rapid Tests

5.4.4. Western Blot Assays

5.4.5. Next Generation Sequencing (NGS)

Chapter 6. Global Blood Screening Market, by Product

6.1. Market Snapshot

6.2. Global Blood Screening Market by Product , Performance-Potential Analysis

6.3. Global Blood Screening Market Estimates & Forecasts by Product 2016-2026 (USD Million)

6.4. Blood Screening Market, Sub Segment Analysis

6.4.1. Reagents & Kits

6.4.2. Instruments

6.4.3. Software & Services

Chapter 7. Global Blood Screening Market, by End-User

7.1. Market Snapshot

7.2. Global Blood Screening Market by End-User , Performance-Potential Analysis

7.3. Global Blood Screening Market Estimates & Forecasts by End-User 2016-2026 (USD Million)

7.4. Blood Screening Market, Sub Segment Analysis

7.4.1. Blood Banks

7.4.2. Hospitals

Chapter 8. Global Blood Screening Market, Regional Analysis

8.1. Blood Screening Market, Regional Market Snapshot

8.2. North America Blood Screening Market

8.2.1. U.S. Blood Screening Market

8.2.1.1. Product breakdown estimates & forecasts, 2016-2026

8.2.1.2. Technology Industry breakdown estimates & forecasts, 2016-2026

8.2.1.3. End-user breakdown estimates & forecasts, 2016-2026

8.2.2. Canada Blood Screening Market

8.3. Europe Blood Screening Market Snapshot

8.3.1. U.K. Blood Screening Market

8.3.2. Germany Blood Screening Market

8.3.3. Rest of Europe Blood Screening Market

8.4. Asia-Pacific Blood Screening Market Snapshot

8.4.1. China Blood Screening Market

8.4.2. India Blood Screening Market

8.4.3. Japan Blood Screening Market

8.4.4. Rest of Asia Pacific Blood Screening Market

8.5. Latin America Blood Screening Market Snapshot

8.5.1. Brazil Blood Screening Market

8.5.2. Mexico Blood Screening Market

8.6. Rest of The World Blood Screening Market

 

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Grifols S.A

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. F. Hoffmann-La Roche AG

9.2.3. Abbott Laboratories

9.2.4. Biomerieux

9.2.5. Bio-Rad Laboratories Inc.

9.2.6. Becton, Dickson and Company

9.2.7. Danaher Corporation

9.2.8. Ortho Clinical Diagnostics

9.2.9. Siemens Healthineers AG

9.2.10. Thermo Fisher Scientific

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption


List Of Figure

FIG 1. GLOBAL BLOOD SCREENING MARKET, RESEARCH METHODOLOGY

FIG 2. GLOBAL BLOOD SCREENING MARKET, MARKET ESTIMATION TECHNIQUES

FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS

FIG 4. GLOBAL BLOOD SCREENING MARKET, KEY TRENDS 2018

FIG 5. GLOBAL BLOOD SCREENING MARKET, GROWTH PROSPECTS 2019-2026

FIG 6. GLOBAL BLOOD SCREENING MARKET, PORTERS 5 FORCE MODEL

FIG 7. GLOBAL BLOOD SCREENING MARKET, PEST ANALYSIS

FIG 8. GLOBAL BLOOD SCREENING MARKET, VALUE CHAIN ANALYSIS

FIG 9. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 10. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 11. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 12. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 13. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 14. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 15. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 16. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 17. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 18. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)

FIG 19. GLOBAL BLOOD SCREENING MARKET, REGIONAL SNAPSHOT 2016 & 2026

FIG 20. NORTH AMERICA BLOOD SCREENING MARKET 2016 & 2026 (USD MILLION)

FIG 21. EUROPE BLOOD SCREENING MARKET 2016 & 2026 (USD MILLION)

FIG 22. ASIA PACIFIC BLOOD SCREENING MARKET 2016 & 2026 (USD MILLION)

FIG 23. LATIN AMERICA BLOOD SCREENING MARKET 2016 & 2026 (USD MILLION)

FIG 24. GLOBAL BLOOD SCREENING MARKET, COMPANY MARKET SHARE ANALYSIS (2018)


List Of Table

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BLOOD SCREENING MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BLOOD SCREENING MARKET

TABLE 3. GLOBAL BLOOD SCREENING MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)

TABLE 7. GLOBAL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD MILLION)

TABLE 8. GLOBAL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD MILLION)

TABLE 9. GLOBAL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)

TABLE 10. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 11. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 12. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 13. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 14. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 15. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 16. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 17. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 18. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 19. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 20. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 21. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 22. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 23. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 24. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 25. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 26. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 27. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 28. GLOBAL BLOOD SCREENING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 29. GLOBAL BLOOD SCREENING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 30. U.S. BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 31. U.S. BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 32. U.S. BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 33. U.S. BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 34. CANADA BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 35. CANADA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 36. CANADA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 37. CANADA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 38. UK BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 39. UK BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 40. UK BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 41. UK BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 42. GERMANY BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 43. GERMANY BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 44. GERMANY BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 45. GERMANY BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 46. ROE BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 47. ROE BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 48. ROE BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 49. ROE BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 50. CHINA BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 51. CHINA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 52. CHINA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 53. CHINA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 54. INDIA BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 55. INDIA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 56. INDIA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 57. INDIA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 58. JAPAN BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 59. JAPAN BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 60. JAPAN BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 61. JAPAN BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 62. ROAPAC BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 63. ROAPAC BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 64. ROAPAC BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 65. ROAPAC BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 66. BRAZIL BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 67. BRAZIL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 68. BRAZIL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 69. BRAZIL BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 70. MEXICO BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 71. MEXICO BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 72. MEXICO BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 73. MEXICO BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 74. ROLA BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 75. ROLA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 76. ROLA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 77. ROLA BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 78. ROW BLOOD SCREENING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 79. ROW BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 80. ROW BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 81. ROW BLOOD SCREENING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Global Blood Screening Market


Companies

Grifols S.A

F. Hoffmann-La Rochen AG

Abbott Laboratories

Biomerieux

Bio-Rad Laboratories Inc.

Becton, Dickson and Company

Danaher Corporation

Ortho Clinical Diagnostics

Siemens Healthineers AG

Thermo Fisher Scientific